Sds Optic (WAR:SDS) Notes Receivable : zł0.00 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Sds Optic Notes Receivable?

Sds Optic's Notes Receivable for the quarter that ended in Mar. 2025 was zł0.00 Mil.

Sds Optic Notes Receivable Historical Data

The historical data trend for Sds Optic's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sds Optic Notes Receivable Chart

Sds Optic Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Notes Receivable

Get a 7-Day Free Trial

Sds Optic Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Notes Receivable	Get a 7-Day Free Trial														-	-	-	-	-

Sds Optic Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Sds Optic Notes Receivable Related Terms

Thank you for viewing the detailed overview of Sds Optic's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sds Optic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sds Optic SA (WAR:SDS) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Gleboka 39, Centrum Ecotech-Complex, Block A, Lublin, POL, 20-612

Website

https://www.sdsoptic.pl

Sds Optic SA is engaged in developing and creating solutions on the borderline of biochemistry, engineering and fiber optic technologies, used in cancer diagnosis and treatment. The company has designed an Opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. The company is also focused on manufacturing Optoelectronics.